Xilio Therapeutics Inc. (XLO)

AI Score

Unlock

AI Score

Our AI model analyzes fundamental, technical, and statistical indicators to predict the probability of a bullish trend over the next three months.

We regularly update and refine our models to deliver the most reliable forecasts for you.

Bullish Probability	Sentiment	Score
+80%	Strong Buy	10
+75%	Buy	9
+70%	Buy	8
+60%	Buy	7
+50%	Hold	6
+45%	Hold	5
+40%	Hold	4
+35%	Sell	3
+30%	Sell	2
+20%	Strong Sell	1

undefined

undefined%

At close: undefined

1.00

1.94%

After-hours Dec 13, 2024, 07:50 PM EST

Income Statement (Annual)

Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.

Boring Mode

Year	FY23	FY22	FY21	FY20	FY19
Revenue	-	-	-	-	-
Cost of Revenue	1.90M	1.85M	1.50M	1.06M	240.00K
Gross Profit	-1.90M	-1.85M	-1.50M	-1.06M	-240.00K
Operating Income	-79.13M	-89.15M	-75.04M	-54.56M	-19.03M
Interest Income	-	-	600.00	600.00	-
Pretax Income	-76.40M	-88.22M	-75.80M	-55.22M	-17.31M
Net Income	-76.40M	-87.30M	-74.30M	-55.22M	-17.31M
Selling & General & Admin	27.00M	29.95M	23.86M	10.65M	4.77M
Research & Development	52.14M	59.20M	51.19M	43.91M	14.26M
Other Expenses	-	927.00K	-756.00K	-656.00K	1.72M
Operating Expenses	79.13M	89.15M	75.04M	54.56M	19.03M
Interest Expense	-	-	600.00K	600.00K	-
Selling & Marketing Expenses	-	-	-	-	-
Cost & Expenses	79.13M	89.15M	75.04M	54.56M	19.03M
Income Tax	-	-927.00K	-1.50M	858.70K	68.14K
Shares Outstanding (Basic)	27.50M	27.39M	27.36M	27.47M	27.47B
Shares Outstanding (Diluted)	27.50M	27.39M	27.36M	27.47M	27.47B
EPS (Basic)	-2.78	-3.19	-2.72	-2.01	-0.00
EPS (Diluted)	-2.78	-3.19	-2.72	-2.01	-0.00
EBITDA	-73.80M	-85.58M	-73.70M	-53.50M	-17.07M
Depreciation & Amortization	1.90M	1.85M	1.50M	1.06M	240.00K